{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:19:40Z","timestamp":1793715580175,"version":"4.6.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670162"],"award-info":[{"award-number":["31670162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Science and Technology Development Plan","award":["20140309007YY"],"award-info":[{"award-number":["20140309007YY"]}]},{"name":"Jilin Provincial Development and Reform Commission","award":["2014Y081"],"award-info":[{"award-number":["2014Y081"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.imlet.2017.07.007","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T16:00:25Z","timestamp":1500307225000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis"],"prefix":"10.1016","volume":"190","author":[{"given":"Yiming","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.07.007_bib0005","series-title":"Global Tuberculosis Report","author":"WHO","year":"2016"},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2017.07.007_bib0010","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2017.07.007_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2213-2600(15)00037-5","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","volume":"3","author":"Ndiaye","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.imlet.2017.07.007_bib0020","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1099\/vir.0.83156-0","article-title":"Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara","volume":"88","author":"Meisinger-Henschel","year":"2007","journal-title":"J. Gen. Virol."},{"issue":"27","key":"10.1016\/j.imlet.2017.07.007_bib0025","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.imlet.2017.07.007_bib0030","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of modified vaccinia virus Ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.imlet.2017.07.007_bib0035","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"8","key":"10.1016\/j.imlet.2017.07.007_bib0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/dna.2006.25.438","article-title":"A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge","volume":"25","author":"Cai","year":"2006","journal-title":"DNA Cell Biol."},{"issue":"16","key":"10.1016\/j.imlet.2017.07.007_bib0045","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2005.12.066","article-title":"Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv","volume":"24","author":"Romano","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imlet.2017.07.007_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vaccine.2009.09.121","article-title":"Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs","volume":"28","author":"Dey","year":"2009","journal-title":"Vaccine"},{"issue":"Pt 8","key":"10.1016\/j.imlet.2017.07.007_bib0055","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1099\/vir.0.81956-0","article-title":"Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells","volume":"87","author":"Havenga","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"7","key":"10.1016\/j.imlet.2017.07.007_bib0060","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/21645515.2015.1042193","article-title":"Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine","volume":"11","author":"Zhang","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.imlet.2017.07.007_bib0065","series-title":"Current Protocols in Molecular Biology","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"2001"},{"key":"10.1016\/j.imlet.2017.07.007_bib0070","series-title":"Current Protocols in Molecular Biology","article-title":"Characterization of recombinant vaccinia viruses and their products","author":"Earl","year":"2001"},{"key":"10.1016\/j.imlet.2017.07.007_bib0075","series-title":"Current Protocols in Molecular Biology","article-title":"Preparation of cell cultures and vaccinia virus stocks","author":"Earl","year":"2001"},{"issue":"1","key":"10.1016\/j.imlet.2017.07.007_bib0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3083.2011.02629.x","article-title":"Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis","volume":"75","author":"You","year":"2012","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2017.07.007_bib0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 Helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis","volume":"71","author":"D\u2019Souza","year":"2003","journal-title":"Infect. Immun."},{"issue":"26","key":"10.1016\/j.imlet.2017.07.007_bib0090","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.vaccine.2016.02.079","article-title":"Status of vaccine research and development of vaccines for tuberculosis","volume":"34","author":"Evans","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2017.07.007_bib0095","doi-asserted-by":"crossref","first-page":"36355","DOI":"10.1038\/srep36355","article-title":"Adenovirally-induced polyfunctional T cells do not necessarily recognize the infected target: lessons from a phase I trial of the AERAS-402 vaccine","volume":"6","author":"Nyendak","year":"2016","journal-title":"Sci. Rep."},{"issue":"205","key":"10.1016\/j.imlet.2017.07.007_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006843","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"48","key":"10.1016\/j.imlet.2017.07.007_bib0105","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2015.10.017","article-title":"Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A","volume":"33","author":"Stylianou","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.imlet.2017.07.007_bib0110","doi-asserted-by":"crossref","first-page":"e40882","DOI":"10.1371\/journal.pone.0040882","article-title":"Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach","volume":"7","author":"Davila","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2017.07.007_bib0115","doi-asserted-by":"crossref","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2017.07.007_bib0120","doi-asserted-by":"crossref","first-page":"e39909","DOI":"10.1371\/journal.pone.0039909","article-title":"The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity","volume":"7","author":"Billeskov","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.imlet.2017.07.007_bib0125","doi-asserted-by":"crossref","first-page":"e72185","DOI":"10.1371\/journal.pone.0072185","article-title":"Comparing adjuvanted H28 and modified vaccinia virus Ankara expressingH28 in a mouse and a non-human primate tuberculosis model","volume":"8","author":"Billeskov","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imlet.2017.07.007_bib0130","doi-asserted-by":"crossref","first-page":"e27529","DOI":"10.4161\/onci.27529","article-title":"A novel minigene scaffold for therapeutic cancer vaccines","volume":"3","author":"Aurisicchio","year":"2014","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.imlet.2017.07.007_bib0135","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.0901356","article-title":"Furin-processed antigens targeted to the secretory route elicit functional TAP1-\/-CD8+ T lymphocytes in vivo","volume":"183","author":"Medina","year":"2009","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"4","key":"10.1016\/j.imlet.2017.07.007_bib0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.imlet.2017.07.007_bib0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/1074-7613(95)90001-2","article-title":"Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice","volume":"2","author":"Flynn","year":"1995","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2017.07.007_bib0150","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.179.3.1449","article-title":"TNF-\u03b1 drives human CD14+\u2009monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses","volume":"179","author":"Iwamoto","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.07.007_bib0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor \u03b1 blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of treg cells","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.imlet.2017.07.007_bib0160","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/IAI.65.11.4843-4849.1997","article-title":"Lethal tuberculosis in interleukin-6-deficient mutant mice","volume":"65","author":"Ladel","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imlet.2017.07.007_bib0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tube.2016.11.005","article-title":"B-lymphocytes forming follicle-like structures in the lung tissue of tuberculosis-infected mice: dynamics, phenotypes and functional activity","volume":"102","author":"Linge","year":"2017","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.imlet.2017.07.007_bib0170","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/IAI.68.6.3322-3326.2000","article-title":"Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection","volume":"68","author":"Saunders","year":"2000","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.imlet.2017.07.007_bib0175","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/infdis\/jit037","article-title":"Role of interleukin 6 in innate immunity to Mycobacterium tuberculosis infection","volume":"207","author":"Martinez","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.imlet.2017.07.007_bib0180","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.4049\/jimmunol.0900646","article-title":"CD69 controls the pathogenesis of allergic airway inflammation","volume":"183","author":"Miki-Hosokawa","year":"2009","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"8","key":"10.1016\/j.imlet.2017.07.007_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1371\/journal.pone.0023700","article-title":"Identification of M. tuberculosis-specific Th1cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.imlet.2017.07.007_bib0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tube.2013.12.007","article-title":"Mycobacterium tuberculosis-specific polyfunctional cytotoxic CD8+ T cells express CD69","volume":"94","author":"Li","year":"2014","journal-title":"Tuberculosis (Edinb.)"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817301888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817301888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T19:01:35Z","timestamp":1602529295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817301888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":38,"alternative-id":["S0165247817301888"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.07.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}